IndiaMTF — home
Stock

Emcure Pharmaceuticals — MTF Book

EMCURE · Emcure Pharmaceuticals Limited
Health Technology

Daily Margin Trading Facility book for Emcure Pharmaceuticals across NSE and BSE, from 01 Jan 2025. All figures in ₹ crore, derived from exchange public disclosures.

What is Emcure Pharmaceuticals’s MTF book?

Emcure Pharmaceuticals Limited (EMCURE) has ₹22 crore funded under Margin Trading Facility across NSE and BSE as of 03 Sep 2026 — 0.01% of India’s MTF book, ranking #997.

Funded value
₹22 Cr
as of 03 Sep 2026
Rank in book
#997
205 days tracked
Share of book
0.01%
of the whole NSE + BSE book
Peak funded
₹35 Cr
on 04 Jul 2025
Largest single-day addition
+₹28 Cr
on 04 Jul 2025
Largest single-day unwind
−₹11 Cr
on 09 Jul 2025
Free-float market cap
₹7,446 Cr
full market cap ₹33,586 Cr · 22.2% free float · Small cap
MTF share of free float
0.30%
0.1× the median small cap · 0.4× the Health Technology median

Share of free float on margin, month by month

Shares under margin at each month-end as a share of free-float shares, using that month-end’s share count and the free-float filing public at the time. It counts shares, not value, so a price move does not move it by itself.

0.17%0.23%0.29%0.35%Jul 2025Sep 2026
View as table: share of free float on margin14 months
Month-end% of free float
03 Sep 2026†0.298%
31 Aug 20260.296%
28 Jul 2026†0.271%
30 Jun 20260.265%
15 May 2026†0.232%
30 Apr 20260.250%
30 Mar 20260.290%
27 Feb 20260.241%
30 Jan 20260.325%
31 Dec 20250.286%
28 Nov 20250.277%
03 Oct 2025†0.211%
12 Aug 2025†0.190%
31 Jul 20250.322%

† Not the month’s last trading day: the last day the stock was in the archive that month (before 11 Nov 2025 the archive kept only the 500 largest positions).

Dated events

NSE & BSE split

How EMCURE’s funded book divides across the two exchanges, as of 03 Sep 2026.
NSE
NSE ₹22 Cr · 97.8%BSE ₹0 Cr · 2.2%

MTF vs Price

Margin-funded outstanding for EMCURE in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where EMCURE has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

EMCURE — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
03 Sep 202622−₹00.01%997
02 Sep 202623−₹10.01%982
01 Sep 202624+₹10.01%969
31 Aug 202622+₹00.01%990
28 Aug 202622−₹10.01%991
27 Aug 202624+₹00.02%970
26 Aug 202624−₹00.02%971
25 Aug 202624+₹10.02%960
24 Aug 202623+₹10.02%971
21 Aug 202623+₹00.01%982
20 Aug 202622+₹10.01%977
19 Aug 202622+₹00.01%990
18 Aug 202622+₹10.01%991
17 Aug 202621−₹00.01%997
06 Aug 202621+₹10.01%976
28 Jul 202620+₹00.01%990
27 Jul 202619+₹00.01%991
24 Jul 202619+₹00.01%993
22 Jul 202619−₹10.01%1000
20 Jul 202620−₹30.01%967
17 Jul 202623+₹20.02%924
16 Jul 202621−₹00.01%952
15 Jul 202622+₹10.01%946
14 Jul 202621+₹10.01%951
13 Jul 202620+₹00.01%977
10 Jul 202619+₹00.01%983
09 Jul 202619+₹10.01%979
08 Jul 202618−₹20.01%988
07 Jul 202620+₹00.01%964
06 Jul 202620—0.01%963
Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.